A Multicenter, Single-arm, Prospective Study of Neoadjuvant Pyrotinib Combined With Trastuzumab Carboplatin and Paclitaxel for ER+/HER2+ Early or Locally Advanced Breast Cancer
Latest Information Update: 23 Aug 2023
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Pyrotinib (Primary)
- Indications Early breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
Most Recent Events
- 23 Aug 2023 New trial record